Package 0469-2602-30

{"route": ["ORAL"], "spl_id": "fe8998d8-cf08-4e07-b966-33e8de20abf1", "openfda": {"nui": ["N0000185008", "N0000185007", "N0000182137", "N0000190114", "N0000185503"], "unii": ["MVR3JL3B2V"], "rxcui": ["1300791", "1300797", "1300801", "1300803", "2541233", "2541237"], "spl_set_id": ["ba9e9e15-e666-4c56-9271-2e24739cfa2d"], "pharm_class_epc": ["beta3-Adrenergic Agonist [EPC]"], "pharm_class_moa": ["Adrenergic beta3-Agonists [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Astellas Pharma US, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": true, "description": "4 CARTON in 1 TRAY (0469-2602-07)  / 1 BLISTER PACK in 1 CARTON / 7 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "0469-2602-07", "marketing_start_date": "20120628"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0469-2602-30)  / 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE", "package_ndc": "0469-2602-30", "marketing_start_date": "20120628"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0469-2602-90)  / 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE", "package_ndc": "0469-2602-90", "marketing_start_date": "20120628"}], "brand_name": "Myrbetriq", "product_id": "0469-2602_fe8998d8-cf08-4e07-b966-33e8de20abf1", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Adrenergic beta3-Agonists [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "beta3-Adrenergic Agonist [EPC]"], "product_ndc": "0469-2602", "generic_name": "mirabegron", "labeler_name": "Astellas Pharma US, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Myrbetriq", "active_ingredients": [{"name": "MIRABEGRON", "strength": "50 mg/1"}], "application_number": "NDA202611", "marketing_category": "NDA", "marketing_start_date": "20120628", "listing_expiration_date": "20261231"}